Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ucommune International Ltd.

1.11
-0.0100-0.89%
Post-market: 1.06-0.0499-4.50%19:54 EDT
Volume:5.75K
Turnover:6.38K
Market Cap:1.60M
PE:-0.35
High:1.12
Open:1.10
Low:1.07
Close:1.12
Loading ...

Holding(s) in Company

Business Wire
·
19 Mar

Shell plc Advances Share Buy-Back Program with Recent Purchases

TIPRANKS
·
19 Mar

Global Trust in Digital Services Declines, Finds Thales

Business Wire
·
18 Mar

Solvonis Advances AWKN-SDN-14 PTSD Treatment Program

TIPRANKS
·
18 Mar

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

GlobeNewswire
·
18 Mar

The Marygold Companies Launches New Fintech App in U.K.

Business Wire
·
17 Mar

Blaize Partners with Turbo Federal to Procure Contracts to Accelerate AI Solutions for the U.S. Department of Defense

Business Wire
·
14 Mar

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Business Wire
·
14 Mar

Shell Announces Leadership Change in Remuneration Committee

TIPRANKS
·
14 Mar

Orbea unveils Denna: A fancy shmancy mid-drive electric road bike tuned for gravel

Electrek
·
14 Mar

Shell plc Executes Share Buy-Back Program to Enhance Shareholder Value

TIPRANKS
·
14 Mar

How Europe Became the Global Hub for Crypto-Friendly Bank

BE[IN]CRYPTO
·
13 Mar

The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets - regulated information

GlobeNewswire
·
12 Mar

Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions

GlobeNewswire
·
12 Mar

Shell plc Advances Share Buy-Back Program

TIPRANKS
·
12 Mar

Net Asset Value(s)

GlobeNewswire
·
11 Mar

Enphase Energy Launches Next-Generation IQ EV Charger across Europe

GlobeNewswire
·
11 Mar

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

Business Wire
·
11 Mar

Caledonia Mining Corporation Plc: Notice of Results and Investor Presentation

GlobeNewswire
·
11 Mar

Blaize to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Business Wire
·
11 Mar